Hayato Hikita

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 29

Top Topics

Hepatitis C Virus

Ejection Fraction

Top Venues

Hepatology research : the official journal of the Japan Society of Hepatology

Hepatology (Baltimore, Md.)

Journal of gastroenterology and hepatology

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Hirayuki Enomoto, Norio Akuta, Hayato Hikita, Goki Suda, Jun Inoue, Nobuharu Tamaki, Kiyoaki Ito, Takemi Akahane, Tomokazu Kawaoka, Akihiro Morishita, Eiichi Ogawa, Ryosuke Tateishi, Hitoshi Yoshiji
Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021. Hepatology research : the official journal of the Japan Society of Hepatology (2024)
Hirayuki Enomoto, Norio Akuta, Hayato Hikita, Goki Suda, Jun Inoue, Nobuharu Tamaki, Kiyoaki Ito, Takemi Akahane, Tomokazu Kawaoka, Akihiro Morishita, Eiichi Ogawa, Ryosuke Tateishi, Hitoshi Yoshiji
Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021. Hepatology research : the official journal of the Japan Society of Hepatology 54 (8) (2024)
Emi Sometani, Hayato Hikita, Kazuhiro Murai, Hidenori Toyoda, Satoshi Tanaka, Tsugiko Oze, Jihyun Sung, Akiyoshi Shimoda, Makoto Fukuoka, Satoshi Shigeno, Keisuke Fukutomi, Kumiko Shirai, Yuki Tahata, Yoshinobu Saito, Akira Nishio, Kunimaro Furuta, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Eiji Mita, Akihiro Umezawa, Yasuhito Tanaka, Tetsuo Takehara
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs. Hepatology research : the official journal of the Japan Society of Hepatology (2024)
Kazuhiro Murai, Hayato Hikita, Takahiro Kodama, Masaki Kaibori, Yuki Nishimura, Tomohide Tatsumi, Tomomi Yamada, Tatsuya Kanto, Satoshi Mochida, Tetsuo Takehara
The impact of the COVID-19 pandemic on hepatocellular carcinoma diagnosis and treatment in Japan - a multicenter collaborative observational study. Hepatology research : the official journal of the Japan Society of Hepatology (2023)
Osamu Yoshida, Sheikh Mohammad Fazle Akbar, Yusuke Imai, Takahiro Sanada, Kyoko Tsukiyama-Kohara, Takashi Miyazaki, Taizou Kamishita, Teruki Miyake, Yoshio Tokumoto, Hayato Hikita, Masataka Tsuge, Masahito Shimizu, Mamun Al Mahtab, Julio Cesar Aguilar, Gerardo Guillen, Michinori Kohara, Yoichi Hiasa
Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow-up results of phase IIa clinical study. Hepatology research : the official journal of the Japan Society of Hepatology (2022)
Yuki Tahata, Ryotaro Sakamori, Kazuki Maesaka, Akira Doi, Ryoko Yamada, Takahiro Kodama, Hayato Hikita, Masanori Miyazaki, Yasutoshi Nozaki, Akira Kaneko, Masahide Oshita, Satoshi Tanaka, Kazuho Imanaka, Naoki Hiramatsu, Naoki Morishita, Kazuyoshi Ohkawa, Takayuki Yakushijin, Mitsuru Sakakibara, Sadaharu Iio, Yoshinori Doi, Tomohide Tatsumi, null And, Tetsuo Takehara
Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology (2022)
Yuki Tahata, Ryotaro Sakamori, Ryoko Yamada, Takahiro Kodama, Hayato Hikita, Yasutoshi Nozaki, Masahide Oshita, Naoki Hiramatsu, Masanori Miyazaki, Eiji Mita, Keiji Yamamoto, Kazuyoshi Ohkawa, Akira Kaneko, Toshifumi Ito, Yoshinori Doi, Takayuki Yakushijin, Taizo Hijioka, Hiroyuki Fukui, Kazuho Imanaka, Yuichi Yoshida, Yukinori Yamada, Tomohide Tatsumi, Tetsuo Takehara
Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis. Hepatology research : the official journal of the Japan Society of Hepatology 52 (10) (2022)
Kazuma Shinkai, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Yasutoshi Nozaki, Kengo Matsumoto, Seiichi Tawara, Kazuto Fukuda, Yuichi Yoshida, Satoshi Tanaka, Toshifumi Ito, Yoshinori Doi, Sadaharu Iio, Mitsuru Sakakibara, Fumihiko Nakanishi, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Prognostic impact of worsening of esophageal varices after balloon-occluded retrograde transvenous obliteration. Journal of gastroenterology and hepatology 37 (6) (2022)
Yuki Tahata, Ryotaro Sakamori, Kazuki Maesaka, Akira Doi, Ryoko Yamada, Takahiro Kodama, Hayato Hikita, Masanori Miyazaki, Yasutoshi Nozaki, Akira Kaneko, Masahide Oshita, Satoshi Tanaka, Kazuho Imanaka, Naoki Hiramatsu, Naoki Morishita, Kazuyoshi Ohkawa, Takayuki Yakushijin, Mitsuru Sakakibara, Sadaharu Iio, Yoshinori Doi, Tomohide Tatsumi, Tetsuo Takehara
Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology (2022)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Akira Doi, Yuki Tahata, Masanori Miyazaki, Kazuyoshi Ohkawa, Eiji Mita, Sadaharu Iio, Yasutoshi Nozaki, Takayuki Yakushijin, Yasuharu Imai, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 52 (7) (2022)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Yasuharu Imai, Kazuyoshi Ohkawa, Masanori Miyazaki, Eiji Mita, Toshifumi Ito, Hideki Hagiwara, Takayuki Yakushijin, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy. Hepatology research : the official journal of the Japan Society of Hepatology 52 (3) (2021)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Masahide Oshita, Hideki Hagiwara, Mitsuru Sakakibara, Shinji Tamura, Naoki Hiramatsu, Masami Inada, Sadaharu Iio, Toshifumi Ito, Takayuki Yakushijin, Yoshinori Doi, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Clinical course of hepatitis C virus-positive patients with decompensated liver cirrhosis in the era of direct-acting antiviral treatment. Hepatology research : the official journal of the Japan Society of Hepatology 51 (5) (2021)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Ayako Urabe, Yuki Tahata, Masahide Oshita, Kazuyoshi Ohkawa, Eiji Mita, Hideki Hagiwara, Shinji Tamura, Toshifumi Ito, Takayuki Yakushijin, Sadaharu Iio, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension. Hepatology research : the official journal of the Japan Society of Hepatology 50 (9) (2020)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Yasuharu Imai, Masahide Oshita, Kazuyoshi Ohkawa, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Initial treatment response to transarterial chemoembolization as a predictive factor for Child-Pugh class deterioration prior to refractoriness in hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 50 (11) (2020)
Yuki Tahata, Ryotaro Sakamori, Ayako Urabe, Ryoko Yamada, Kazuyoshi Ohkawa, Naoki Hiramatsu, Hideki Hagiwara, Masahide Oshita, Yasuharu Imai, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Clinical outcomes of direct-acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment. Hepatology research : the official journal of the Japan Society of Hepatology 50 (10) (2020)
Yuki Tahata, Ryotaro Sakamori, Ayako Urabe, Ryoko Yamada, Kazuyoshi Ohkawa, Naoki Hiramatsu, Hideki Hagiwara, Masahide Oshita, Taizo Hijioka, Shinji Tamura, Yasuharu Imai, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Hepatocellular carcinoma occurrence does not differ between interferon-based and interferon-free treatment with liver histological assessment. Hepatology research : the official journal of the Japan Society of Hepatology 50 (3) (2020)
Ryoko Yamada, Naoki Hiramatsu, Tsugiko Oze, Ayako Urabe, Yuki Tahata, Naoki Morishita, Takahiro Kodama, Hayato Hikita, Ryotaro Sakamori, Takayuki Yakushijin, Akira Yamada, Hideki Hagiwara, Eiji Mita, Masahide Oshita, Toshifumi Itoh, Hiroyuki Fukui, Yoshiaki Inui, Taizo Hijioka, Masami Inada, Kazuhiro Katayama, Shinji Tamura, Atsuo Inoue, Yasuharu Imai, Tomohide Tatsumi, Toshimitsu Hamasaki, Norio Hayashi, Tetsuo Takehara
Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response. Hepatology research : the official journal of the Japan Society of Hepatology 49 (5) (2019)
Yoichi Sasaki, Ryotaro Sakamori, Ryoko Yamada, Minoru Shigekawa, Yuki Tahata, Yuki Makino, Tasuku Nakabori, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Cotreatment with lenvatinib and warfarin potassium caused prothrombin time prolongation. Hepatology research : the official journal of the Japan Society of Hepatology 49 (11) (2019)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Ayako Urabe, Minoru Shigekawa, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 50 (3) (2019)
Ayako Urabe, Ryotaro Sakamori, Yuki Tahata, Ryoko Yamada, Yasuharu Imai, Hideki Hagiwara, Shinji Tamura, Hiroyuki Fukui, Yukinori Yamada, Akira Kaneko, Taizo Hijioka, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Predictive factors of anemia during sofosbuvir and ribavirin therapy for genotype 2 chronic hepatitis C patients. Hepatology research : the official journal of the Japan Society of Hepatology 49 (8) (2019)
Yuki Tahata, Ryotaro Sakamori, Ayako Urabe, Naoki Morishita, Ryoko Yamada, Takayuki Yakushijin, Naoki Hiramatsu, Yoshinori Doi, Akira Kaneko, Hideki Hagiwara, Yukinori Yamada, Taizo Hijioka, Masami Inada, Shinji Tamura, Yasuharu Imai, Kunimaro Furuta, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C. Hepatology communications 2 (8) (2018)
Takeo Yoshihara, Ryotaro Sakamori, Kunimaro Furuta, Minoru Shigekawa, Ryoko Yamada, Takahiro Kodama, Hayato Hikita, Takayuki Yakushijin, Tomohide Tatsumi, Yasushi Sakata, Hidetoshi Eguchi, Yoshiki Sawa, Tetsuo Takehara
Hepatocellular carcinoma due to a baffle obstruction after the mustard operation: A case report. Hepatology (Baltimore, Md.) 67 (6) (2018)
Akira Doi, Hayato Hikita, Ryotaro Sakamori, Yuki Tahata, Yugo Kai, Ryoko Yamada, Takayuki Yakushijin, Eiji Mita, Kazuyoshi Ohkawa, Yasuharu Imai, Kunimaro Furuta, Takahiro Kodama, Tomohide Tatsumi, Tetsuo Takehara
Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection. Hepatology (Baltimore, Md.) 68 (1) (2018)
Mayumi Egawa, Yuichi Yoshida, Satoshi Ogura, Tomohide Kurahashi, Takashi Kizu, Kunimaro Furuta, Yoshihiro Kamada, Norihiro Chatani, Mina Hamano, Shinichi Kiso, Hayato Hikita, Tomohide Tatsumi, Hidetoshi Eguchi, Hiroaki Nagano, Yuichiro Doki, Masaki Mori, Tetsuo Takehara
Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 47 (11) (2017)
Akira Doi, Ryotaro Sakamori, Yuki Tahata, Ayako Urabe, Naoki Morishita, Ryoko Yamada, Kunimaro Furuta, Takahiro Kodama, Hayato Hikita, Takayuki Yakushijin, Kazuyoshi Ohkawa, Akira Kaneko, Yasuharu Imai, Tomohide Tatsumi, Tetsuo Takehara
Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohort. Hepatology research : the official journal of the Japan Society of Hepatology 47 (13) (2017)
Atsushi Hosui, Tomohide Tatsumi, Hayato Hikita, Yoshinobu Saito, Naoki Hiramatsu, Masahiko Tsujii, Lothar Hennighausen, Tetsuo Takehara
Signal transducer and activator of transcription 5 plays a crucial role in hepatic lipid metabolism through regulation of CD36 expression. Hepatology research : the official journal of the Japan Society of Hepatology 47 (8) (2016)
Akira Nishio, Tomohide Tatsumi, Takatoshi Nawa, Takahiro Suda, Teppei Yoshioka, Yoshiki Onishi, Satoshi Aono, Minoru Shigekawa, Hayato Hikita, Ryotaro Sakamori, Daisuke Okuzaki, Takasuke Fukuhara, Yoshiharu Matsuura, Naoki Hiramatsu, Tetsuo Takehara
CD14+ monocyte-derived galectin-9 induces natural killer cell cytotoxicity in chronic hepatitis C. Hepatology (Baltimore, Md.) 65 (1) (2016)
Naoki Morishita, Naoki Hiramatsu, Tsugiko Oze, Ayako Urabe, Yuki Tahata, Ryoko Yamada, Takayuki Yakushijin, Atsushi Hosui, Sadaharu Iio, Akira Yamada, Hideki Hagiwara, Eiji Mita, Yukinori Yamada, Toshifumi Ito, Masami Inada, Kazuhiro Katayama, Iwao Yabuuchi, Yasuharu Imai, Hayato Hikita, Ryotaro Sakamori, Yuichi Yoshida, Tomohide Tatsumi, Norio Hayashi, Tetsuo Takehara
Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection. Hepatology research : the official journal of the Japan Society of Hepatology 47 (8) (2016)
Satoshi Tanaka, Hayato Hikita, Tomohide Tatsumi, Ryotaro Sakamori, Yasutoshi Nozaki, Sadatsugu Sakane, Yuto Shiode, Tasuku Nakabori, Yoshinobu Saito, Naoki Hiramatsu, Keisuke Tabata, Tsuyoshi Kawabata, Maho Hamasaki, Hidetoshi Eguchi, Hiroaki Nagano, Tamotsu Yoshimori, Tetsuo Takehara
Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice. Hepatology (Baltimore, Md.) 64 (6) (2016)